| Literature DB >> 17187664 |
Catherine E Chambers1, Erika I Lutter, Michelle B Visser, Peggy P Y Law, Pamela A Sokol.
Abstract
BACKGROUND: The Burkholderia cenocepacia CepIR quorum sensing system has been shown to positively and negatively regulate genes involved in siderophore production, protease expression, motility, biofilm formation and virulence. In this study, two approaches were used to identify genes regulated by the CepIR quorum sensing system. Transposon mutagenesis was used to create lacZ promoter fusions in a cepI mutant that were screened for differential expression in the presence of N-acylhomoserine lactones. A bioinformatics approach was used to screen the B. cenocepacia J2315 genome for CepR binding site motifs.Entities:
Mesh:
Substances:
Year: 2006 PMID: 17187664 PMCID: PMC1766932 DOI: 10.1186/1471-2180-6-104
Source DB: PubMed Journal: BMC Microbiol ISSN: 1471-2180 Impact factor: 3.605
Figure 1Functional analysis of the CepR binding site. A. Site directed mutagenesis was used to determine the effects of mutations on the luminescence activity of a cepI::luxCDABE fusion. The sequence upstream of the CepI ORF is shown. The ATG start codon is indicated by bold lettering and the predicted -10 hexamer is underlined. A series of 4 bp substitutions used to mutate the promoter region are indicated as bx303-313 and the cep box consensus sequence is enclosed in the rectangle. B. Expression of the cepI::luxCDABE fusions in B. cenocepacia K56-2. Luminescence (CPM) was measured at 22 hours and is represented as CPM/O.D. The numbers on the x axis indicate K56-2 (pCPI303-313) respectively. WT is K56-2 (pCPI301) and the vector control is K56-2 (pMS402).
OHL responsive genes identified by Tn5-OT182 mutagenesis of K56-I2
| Transposon Mutant | Orfa | Predicted start codonb | Location of insertb | Gene/domain homologyc | OHL effect on expressiond |
| K56-I2-P1, K56-I2-P2 | BCAM0392 | 2:445357 | 2:444971 | COG1835: Predicted acyltransferases | + |
| K56-I2-P3 | BCAM0957 | 2:1062298 | 2:1060868 | + | |
| K56-I2-P5, K56-I2-P10 | BCAS0293 | 3:328037 | 3:328810 | + | |
| K56-I2-P9 | BCAM2631 | 2:2981279 | 2:2980753 | COG2860: predicted membrane protein | - |
| K56-I2-P12 | BCAM2630 | 2:2979794 | 2:2980345 | + | |
| K56-I2-2PB2 | no gene | 2:2980336 | - | ||
| K56-I2-NB12 | BCAM1187 | 2:1298085 | 2:1297891 | COG4774, Outer membrane receptor | - |
a Open reading frame designation from the unpublished annotation of the B. cenocepacia J2315 genome.
b Locations reported as chromosome:nucleotide.
c Gene and domain homologies determined using BLASTP.
d Effect of OHL on expression of the lacZ fusion created by insertion of the transposon. +, positive regulation or greater expression in the presence of OHL; -, negative regulation or lower expression in the presence of OHL.
Figure 2Effect of OHL on β-galactosidase activity in K56-I2 Tn. A: Growth curves for strains shown in panels B-H. (●) CLW101; (▲) K56-I2-P1; (▼) K56-I2-P3; (□) K56-I2-P9; (◊) K56-I2-P10; (■) K56-I2-P12; (○) K56-I2-NB12; and (*) K56-I2-2PB2. Panels B-H: β-galactosidase activity with (■) and without (□) OHL. Fifty μl of OHL obtained from extracts from a 50 ml culture purified by FPLC and resuspended in 1 ml were added to 10 ml broth. This volume of OHL was shown to restore cepI expression to maximum levels. B: CLW101, C: K56-I2-P1, D: K56-I2-P10, E: K56-I2-P12, F: K56-I2-NB12, G: K56-I2-P9 and H: K56-I2-2PB2.
Figure 3Expression of promoter::. The promoter fusions in pMS402 were introduced into strains K56-2 (●), K56-dI2 with no OHL (▼), K56-dI2 with 25 nM OHL (▲) and K56-R2 (■). Strains were grown in triplicate in 96 well microtitre plates for 24 hours. Luminescence and optical density were measured at various timepoints and the activity of the promoter was calculated as CPM/O.D. A. pCPI301 (cepI), B. pAID301 (aidA), C. pAYL301(acyltransferase), and D. pHMV301(phuR).
Identification of a cep box consensus motif.
| Gene | direction | Sequencec | bp to ORFd | |
| First Generation Motif Sequencesa | ||||
| 2.23E-11 | + | CACC | 72 | |
| 6.53E-10 | + | TACA | 116 | |
| 2.24E-09 | - | GAAG | 159 | |
| 2.60E-09 | + | TCTT | 54 | |
| Acyltransferase | 1.13E-07 | - | AGGG | 3 |
| 1.25E-07 | - | CCAG | 115 | |
| Second Generation Motif Sequencesf | ||||
| 4.79E-11 | + | CACC | 72 | |
| 6.11E-11 | + | TACA | 116 | |
| MST072 | 4.01E-09 | + | AAAA | 56 |
| 2.16E-08 | - | GAAG | 159 | |
| MST028 | 5.32E-07 | - | CTTT | 140 |
| 2.60E-09 | + | TCTT | 54 | |
| MST005 | 1.24E-06 | + | CAAC | 206 |
| MST068 | 1.60E-06 | - | CGTT | 138 |
| MST011 | 1.80E-06 | + | TGTC | 76 |
| MST059 | 2.41e-06 | + | ATGG | 118 |
a The promoter regions of 6 genes experimentally determined to be positively regulated by CepR used to search for common motifs with the MEME (Multiple EM for Motif Elicitation) program.
b The p-value of a site is computed from the the match score of the site with the position specific scoring matrix for the motif. The p-value gives the probability of a random string (generated from the background letter frequencies) having the same match score or higher. (This is referred to as the position by the MAST algorithm.)
c The boxed region represents the region determined to be required for cepI expression as determined in Fig. 1. Bold lettering represents the motif predicted by the MEME program. In the case of cepI the motif matches the CepR binding site [20].
d The number of base pairs to the start codons predicted by alignment with homologous genes.
e Underlined bases are conserved in at least 4 of 6 sequences.
f The promoter regions of 10 genes experimentally determined to be positively regulated by CepR used to search for common motifs with MEME.
g Underlined bases are conserved in at least 7 of 10 sequences.
Figure 4Expression of promoter::. The promoter fusions in pMS402 were introduced into strains K56-2 (○), K56-dI2 with no OHL (▼), K56-dI2 with 25 nM OHL (▲) and K56-R2 (■). A. MST005, B. MST011, C. MST028, D. MST052, E. MST059, F. MST068, G. MST072, H. MST112. Strains were grown in triplicate in 96 well microtitre plates for 24 hours. Luminescence and optical density were measured at various timepoints and the activity of the promoter was calculated as CPM/O.D.
Figure 5Graphical representation of the . Nucleotide sequence logos are derived from the sequences in Table 2. The relative sizes of the letters indicate their likelihood of occurring at a particular position. The upper logo is based on the six sequences used in the first generation consensus search and the lower logo is based on the ten sequences used in the second generation consensus search.
B. cenocepacia J2315 genes identified using the second generation cep box motif
| Motif namea | Positionb | bpc | gened | Gene/domain and predicted functione |
| MST2008 (-) | 1:806161 | 45 | BCAL0738(-) | COG0793: Periplasmic protease; cell envelope biogenesis |
| MST2009 (+) | 1:901874 | 295 | BCAL0831 (+) | |
| MST2031 (-) | 1:2662911 | 104 | BCAL2406(-) | COG0859, |
| MST2048 (-) | 2:211218 | 106 | BCAM0183 (+) | COG3468, autotransporter type V secretion, |
| MST2050 (+) | 2:1129604 | 172 | BCAM1015(-) | COG3203: Outer membrane protein |
| MST2068 (-) | 3:174253 | 153 | BCAS0156(+) | COG1680: ampC, β-lactamase class C |
| MST2014 (-) | 1:1228119 | 131 | BCAL1124 (+) | Conserved hypothetical protein |
| 1:1484174 | 140 | BCAL1354(-) | COG4104: conserved hypothetical protein ( | |
| MST2030 (-) | 1:2567308 | 41 | BCAL2313 (+) | hypothetical protein |
| MST2052 (+) | 2:1249946 | 118 | BCAM1149 (+) | hypothetical protein |
| MST2056 (-) | 2:1667312 | 57 | BCAM1502 (+) | hypothetical protein (Chemoreceptor |
| MST2063 (-) | 2:2720454 | -19 | BCAM2417 (+) | hypothetical protein |
| MST2067 (+) | 2:3070180 | 254 | BCAM2713(-) | hypothetical protein |
| MST2071 (+) | 3:836110 | 63 | BCAS0753(+) | hypothetical protein |
| MST2002 (-) | 1:273243 | 21 | BCAL0232 (+) | Elongation factor Tu |
| MST2005 (+) | 1:390962 | 47 | BCAL0358 (-) | COG0308: Aminopeptidase N |
| 1:778996 | 101 | BCAL0716 (+) | COG1250: | |
| MST2010 (-) | 1:963495 | 59 | BCAL0886 (+) | COG0183: |
| MST2022 (-) | 1:1602043 | 50 | BCAL1448(-) | COG0525: |
| MST2023 (-) | 1:1626201 | 104 | BCAL1468(-) | COG0644: |
| MST2027 (+) | 1:2465614 | 32 | BCAL2229(-) | Hypothetical signal peptide protein (COG3000: Sterol desaturase, lipid metabolism) |
| MST2029 (-) | 1:2554533 | 153 | BCAL2302(-) | COG0556, |
| MST2029 (-) | 1:2554533 | 106 | BCAL2303 (+) | COG1448, |
| MST2034 (+) | 1:2903040 | 55 | BCAL2638 (+) | COG0165, |
| MST2035 (+) MST052 | 1:3009329 | 9 | BCAL2739 (+) | COG0480, |
| MST2038 (+) | 1:3351536 | -15 | BCAL3058 (+) | COG0043, |
| 1:3488874 | 117 | BCAL3191(+) | COG1960: | |
| MST2043 (+) | 1:3745369 | 60 | BCAL3419 (+) | COG0757: |
| MST2045 (+) | 2:11142 | 137 | BCAM0010(+) | |
| 2:84847 | 55 | BCAM0077(-) | COG0654: | |
| MST2055 (+) | 2:1564008 | 139 | BCAM1405(-) | |
| 2:2088113 | 71 | BCAM1870 (+) | ||
| MST2061(+) | 2:2134837 | 112 | BCAM1922(+) | |
| MST2064 (-) | 2:2839793 | 44 | BCAM2502(-) | COG0757: |
| MST2064 (-) | 2:2839793 | 125 | BCAM2503(+) | COG3185: |
| MST2065 (-) | 2:2938113 | 48 | BCAM2588(-) | |
| MST2024 (+) | 1:1735446 | 71 | BCAL1564 (-) | Hypothetical proteins Mup46, Mup47 and Mup48 [phage tail protein] |
| MST2060 (+) | 2:2096677 | 28 | BCAM1879 (+) | Phage antirepressor |
| MST2006 (-) | 1:616909 | 88 | BCAL0562(-) | COG2747, |
| 1:778996 | 59 | BCAL0715(-) | COG0583: LysR-type transcriptional regulator | |
| MST2013 (+) | 1:1085981 | 40 | BCAL0999 (+) | COG3073: RseA; Negative regulator of sigma E activity (RseB or MucB, negative regulator for alginate biosynthesis) |
| MST2019 (-) | 1:1437591 | 385 | BCAL1318 (+) | COG3707, |
| MST2026 (+) | 1:2016418 | 259 | BCAL1826 (+) | |
| MST2036 (-) | 1:3153030 | 18 | BCAL2871(-) | COG3073, |
| 1:3488874 | 102 | BCAL3190(-) | COG1414: Transcriptional regulator, IclR family | |
| MST2040 (-) | 1:3502381 | 36 | BCAL3205(-) | COG1396: |
| 2:11142 | 22 | BCAM0009(-) | COG1396: | |
| 2:84847 | 58 | BCAM0076(-) | COG1309: ArcR domain: Bacterial regulatory proteins, tetR family | |
| MST2055(+) | 2:1564008 | 64 | BCAM1406(+) | COG: |
| MST2057 (+) | 2:1959876 | 36 | BCAM1750 (+) | COG1846: Transcriptional regulator, MarR family |
| MST2058f (+) | 2:2087487 | 31 | BCAM1868(-) | |
| MST2071 (+) | 3:836110 | 40 | BCAS0752(-) | COG0583: LysR type Transcriptional regulator |
| MST2003 (+) | 1:351306 | 25 | BCAL0321 (+) | COG3671: Predicted membrane protein ( |
| 1:366026 | 206 | BCAL0340 (+) | COG0457: TPR repeat, ( | |
| 3:478440 | 108 | BCAS0409 (+) | ||
| Transport | ||||
| MST2001 (-) | 1:61816 | 272 | BCAL0051 (+) | COG0834: ABC-type amino acid transport/signal transduction systems |
| 2:2974227 | 115 | BCAM2626 (+) | ||
| MST2072 (+) | P:55610 | 113 | PBCA053 (-) | COG1638, |
| Unknown | ||||
| 1:366026 | 181 | BCAL0339(-) | COG3521: Uncharacterized protein conserved in bacteria | |
| MST2025 (+) | 1:1979817 | 274 | BCAL1791 (-) | COG2606: Uncharacterized conserved protein |
| MST2047 (-) | 2:169540 | 86 | BCAM0148 (+) | Putative vgr-related protein ( |
| MST2051 (-) | 2:1150388 | -37 | BCAM1044(-) | no homology (COG1536: Flagellar motor switch protein) |
| MST2053 (-) | 2:1467792 | 28 | BCAM1328-329 (+) | Unknown proteins |
| MST2061 (+) | 2:2134837 | 59 | BCAM1921-919 (-) | no homologs |
| 3:329197 | 160 | BCAS0293(-) | ||
a MSTs were identified by searching the B. cenocepacia J2315 genome with the position specific scoring matrix (PSSM) from the second generation motif. Only genes with a motif match within a potential promoter and within 300 bp of the predicted start codon are reported.
b The location center of the predicted motif is reported as chromosome:nucleotide. (+) or (-) refers to the DNA strand encoding the motif sequence. The motif names in bold were used to generate the PSSM file.
c Number of base pairs between the centre of the motif and the predicted translational start site.
d Open reading frame number from the unpublished annotation of the B. cenocepacia J2315 genome. (+) and (-) refer to the DNA strand.
e Gene and domain homologies were obtained using the standard protein-protein BlastP program as described in the methods. Genes in parantheses are downstream of the first orf following the motif and may be in the same operon.
f Confirmed to be CepR regulated by either lux or lacZ transcriptional fusions.
Figure 6Alignment of the putative . The MST sequences listed are described in Table 3. Bases conserved in at least 70% of the sequences are shown in red and indicated by an upper case letter in the consensus sequence at the bottom of the alignment, and those conserved in at least 50% of the sequences are shown in blue and indicted by a lower case letter in the consensus sequence. Other bases are indicated in black.
Bacterial strains and plasmids used in this study.
| Strain or plasmid | Description and relevant genotype | Source |
| DH5α | φ80d | Invitrogen |
| SM10 | Mobilizing strain, RP4 | [50] |
| DH10B | F- | Invitrogen |
| JM109 F' | Promega | |
| K56-2 | Cystic fibrosis respiratory isolate | [51] |
| K56-R2 | [11] | |
| K56-I2 | [11] | |
| K56-dI2 | [35] | |
| CLW101 | [20] | |
| K56-I2-P1 | BCAM03092:: Tn | This study |
| K56-I2-P3 | BCAM0957:: Tn | This study |
| K56-I2-P5 | BCAS0293:: Tn | This study |
| K56-I2-P9 | BCAM2631:: Tn | This study |
| K56-I2-P12 | BCAM2630:: Tn | This study |
| K56-I2-2PB2 | Tn | This study |
| K56-I2-NB12 | BCAM1187:: Tn | This study |
| Plasmids | ||
| pCR®2.1 TOPO | PCR cloning vector, pUC ori, P | Invitrogen |
| pOT182 | pSUP102(GM)::Tn | [40] |
| pALTER®- | mutagenesis plasmid, Tcr | Promega |
| pSLS225 | pUCP26 with 1.5 kb | [11] |
| pCPI101 | pCR®2.1 TOPO with a 266 bp fragment containing the | This study |
| pCPI201 | pAlter®- | This study |
| pMS402 | Broad host range vector with promoterless | [29] |
| pCPI301 | pMS402 with the | This study |
| pCPI303-313 | pMS402 containing the | This study |
| pRK2013 | ColE1 Tra (RK2)+, Kmr | [52] |
| pPHU301 | pMS402 containing the | This study |
| pAYL301 | pMS402 containing the acyltransferase promoter region | This study |
| pSCP301 | pMS402 containing the | This study |
| pAID301 | pMS402 containing the | This study |
| pMST005 | pMS402 containing the MST005 promoter region | This study |
| pMST011 | pMS402 containing the MST011 promoter region | This study |
| pMST028 | pMS402 containing the MST028 promoter region | This study |
| pMST052 | pMS402 containing the MST052 promoter region | This study |
| pMST059 | pMS402 containing the MST059 promoter region | This study |
| pMST068 | pMS402 containing the MST068 promoter region | This study |
| pMST112 | pMS402 containing the MST112 promoter region | This study |
Oligonucelotide primers
| Primer | Sequence | Restriction Site or size of product (bp) | |
| PCR Oligonucleotides | |||
| cepIfor | CAGGCGGCGATAGCTTG | ||
| cepIrev | CACAGATCCGAGGACATCCA | ||
| EXcepR3 | CG | ||
| EXcepR2 | CG | ||
| oligonucleotides used to clone promoters | position of 5' basea | Size (bp) | |
| CAGATTCAATGTCGCG | 3:329288 | 272 | |
| GCACATCGGTAACGCG | 3:329016 | ||
| CTGCAACGAACGACGCG | 2:1062555 | 294 | |
| GACGGAAGGGGAAGGGC | 2:1062261 | ||
| GCCTGCAGGGCACAACGACGCCTATCATGC | 2:2087932 | 267 | |
| GAACGAAGGTCTGCATGGATG | 2:2088199 | ||
| PBP | CGTCGGGAACGAGGCCC | 2:2983704 | 313 |
| CGATGGGTTGGCGGTGGG | 2:2983391 | ||
| CGTGTCGATGATCCGCG | 2:2973940 | 404 | |
| CACAGGTGGTCTCCC | 2:2974344 | ||
| acyltransferase | CGATACACTGTGAGCCG | 2:446287 | 336 |
| GTCCTTCAGCACGCCG | 2:445951 | ||
| CTCGAGGCTGGCCGGTACTG | 3:478051 | 638 | |
| GGATCCAGACTGAAGGCGGACG | 3:478689 | ||
| MST005 | GCACGCCCGCGTCAGGCG | 1:366108 | 325 |
| CGCAAGCCACCACTACCCC | |||
| MST011 | CCTTGCTGAGATTGCCGGC | 1:779005 | 321 |
| GACAGCGCGTTCACGGGCG | |||
| MST028 | CGTGTCGTTGCGGCGCGC | 1:1484174 | 451 |
| GTCTGGCTGTACGCACGCC | |||
| MST052 | CCGTCATTTGTCGTCGGGC | 1:3009328 | 341 |
| CCAGTCCATCGTGGCCGC | |||
| MST059 | CGCCTTCGGCAGCCCCG | 1:3488873 | 315 |
| GCTGGTCGAGCAGCAGCGG | |||
| MST068 | CGTCGAGCGTCAGCTTGCGC | 2:11203 | 325 |
| GGTCGAGCGTCCCGCGC | |||
| MST072 | GCATCCAGCAGGCGCGC | 2:84846 | 398 |
| CCGACGGGACCGCAGCCC | |||
| MST112 | GCAGGTCGCCATGCCGGG | 2:2156170 | 441 |
| ACCACGCGTACGCGGGC | |||
| Mutagenic Oligonucleotides | |||
| CepBx103 | GCGTCTTTACGC | ||
| CepBx104 | GTCTTTACGCCGT | ||
| CepBx105 | CGCCGTCACCC | ||
| CepBx106 | GCCGTCACCCTG | ||
| CepBx107F | ACGCCGTCACCCTGTA | ||
| CepBx107R | GAGGAGCCTGTAACTGGT | ||
| CepBx108F | CCGTCACCCTGTAAGAG | ||
| CepBx108R | GCACGAGGAGCCTGTAAC | ||
| CepBx109F | CACCCTGTAAGAGTTACC | ||
| CepBx109R | GCGCGGCACGAGGAGCCT | ||
| CepBx110F | CCTGTAAGAG TTACCAGTTA | ||
| CepBx110R | CAGCGCGCGG CACGAGG | ||
| CepBx111F | AGAGTTACCAGTTACAGG | ||
| CepBx111R | CATTACAGCGCGCGGCAC | ||
| CepBx112F | GTTACCAGTTACAGGCTC | ||
| CepBx112R | GTGCATTACAGCGCGCGG | ||
| CepBx113F | CCAGTTACAGGCTCCTC | ||
| CepBx113R | GCGTGCATTACAGCGCG | ||
a Locations reported as chromosome:nucleotide